{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:02:14Z","timestamp":1756893734436},"reference-count":49,"publisher":"Japan Atherosclerosis Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,7,1]]},"DOI":"10.5551\/jat.63725","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T22:13:09Z","timestamp":1664403189000},"page":"735-753","source":"Crossref","is-referenced-by-count":6,"title":["Relationship between Diabetes Mellitus and Serum Lathosterol and Campesterol Levels: The CACHE Study DM Analysis"],"prefix":"10.5551","volume":"30","author":[{"given":"Takeshi","family":"Matsumura","sequence":"first","affiliation":[{"name":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Ishigaki","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Nakagami","sequence":"additional","affiliation":[{"name":"Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women\u2019s Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Respiratory and Geriatric Medicine, Kyushu University Beppu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Shimane University Faculty of Medicine"},{"name":"Jinjyukai Education &amp; Training Center for Healthcare Professionals"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Ishida","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisako","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Health and Medical Innovation, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Harada-Shiba","sequence":"additional","affiliation":[{"name":"Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daijiro","family":"Kabata","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuki","family":"Kihara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Kotani","sequence":"additional","affiliation":[{"name":"Division of Community and Family Medicine, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kurisu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisaku","family":"Masuda","sequence":"additional","affiliation":[{"name":"Rinku General Medical Center, Izumisano"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Matsuki","sequence":"additional","affiliation":[{"name":"Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute"},{"name":"Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kobe University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Nakazato","sequence":"additional","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satsuki","family":"Taniuchi","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ueno","sequence":"additional","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuya","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Rinku General Medical Center, Izumisano"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Jikei University Kashiwa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisako","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Shoji","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Osaka Metropolitan University Graduate School of Medicine"},{"name":"Vascular Science Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation, 1999; 100: 1134-1146","DOI":"10.1161\/01.CIR.100.10.1134"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tonelli M, Muntner P, Lloyd A, Manns BJ, Klarenbach S, Pannu N, James MT, Hemmelgarn BR; Alberta Kidney Disease Network: Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet, 2012; 380: 807-814","DOI":"10.1016\/S0140-6736(12)60572-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J: Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet, 2010; 375: 2215-2222","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med, 1998; 339: 229-234","DOI":"10.1056\/NEJM199807233390404"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M: Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science, 2004; 303: 1201-1204","DOI":"10.1126\/science.1093131"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR Jr, Dean DC, Detmers PA: The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA, 2005; 102: 8132-8137","DOI":"10.1073\/pnas.0500269102"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Brown MS, Goldstein JL: Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J lipid Res, 1980; 21: 505-517","DOI":"10.1016\/S0022-2275(20)42221-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Miettinen TA, Tilvis RS, Kesaniemi YA: Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol, 1990; 131: 20-31","DOI":"10.1093\/oxfordjournals.aje.a115479"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Strandberg TE, Tilvis RS, Pitkala KH, Miettinen TA: Cholesterol and glucose metabolism and recurrent cardiovascular events among the elderly: a prospective study. J Am Coll Cardiol, 2006; 48: 708-714","DOI":"10.1016\/j.jacc.2006.04.081"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Matthan NR, Pencina M, LaRocque JM, Jacques PF, D&apos;Agostino RB, Schaefer EJ, Lichtenstein AH: Alterations in cholesterol absorption\/synthesis markers characterize Framingham offspring study participants with CHD. J Lipid Res, 2009; 50: 1927-1935","DOI":"10.1194\/jlr.P900039-JLR200"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lally S, Tan CY, Owens D, Tomkin GH: Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann\u2013Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein. Diabetologia, 2006; 49: 1008-1016","DOI":"10.1007\/s00125-006-0177-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbal\u00e1n R, \u0160pinar J, Park JG, White JA, Bohula EA, Braunwald E; IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators: Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, 2018; 137: 1571-1582","DOI":"10.1161\/CIRCULATIONAHA.117.030950"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Gylling H, Miettinen TA: Cholesterol absorption, synthesis and LDL metabolism in NIDDM. Diabetes Care, 1997; 20: 90-95","DOI":"10.2337\/diacare.20.1.90"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Simonen PP, Gylling HK, Miettinen TA: Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care, 2002; 25: 1511-1515","DOI":"10.2337\/diacare.25.9.1511"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Bennion LJ, Grundy SM: Effects of diabetes mellitus on cholesterol metabolism in man. N Engl J Med, 1977; 296: 1365-1371","DOI":"10.1056\/NEJM197706162962401"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Abrams JJ, Ginsberg H, Grundy SM: Metabolism of cholesterol and triglycerides in nonketotic diabetes mellitus. Diabetes, 1982; 31: 903-1910","DOI":"10.2337\/diabetes.31.10.903"},{"key":"17","unstructured":"17) Andersen E, Hellstr\u00a8om P, Hellstr\u00a8om K: Cholesterol and bile acid metabolism in middle-aged diabetics. Diabete Metab, 1986; 12: 261-266"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Briones ER, Steiger DL, Palumbo PJ, O&apos;Fallon WM, Langworthy AL, Zimmerman BR, Kottke BA: Sterol excretion and cholesterol absorption in diabetics and nondiabetics with and without hyperlipidemia. Am J Clin Nutr, 1986; 44: 353-361","DOI":"10.1093\/ajcn\/44.3.353"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Shoji T, Akiyama Y, Fujii H, Harada-Shiba M, Ishibashi Y, Ishida T, Ishigaki Y, Kabata D, Kihara Y, Kotani K, Kurisu S, Masuda D, Matoba T, Matsuki K, Matsumura T, Mori K, Nakagami T, Nakazato M, Taniuchi S, Ueno H, Yamashita S, Yoshida H, Yoshida H: Association of Kidney Function with Serum Levels of Cholesterol Absorption and Synthesis Markers: The CACHE Study CKD Analysis. J Atheroscler Thromb, 2022; 29: 1835-1848","DOI":"10.5551\/jat.63311"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N and Conde JG: Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform, 2009; 42: 377-381","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O&apos;Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN, Consortium RE: The REDCap consortium: Building an international community of software platform partners. J Biomed Inform, 2019; 95: 103208","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care, 2014; 37: S81-90","DOI":"10.2337\/dc14-S081"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus; Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M and Ueki K: Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig, 2010; 1: 212-228","DOI":"10.1111\/j.2040-1124.2010.00074.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M, Yamakado M, Yatomi Y, Ohashi H, Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society: International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig, 2012; 3: 39-40","DOI":"10.1111\/j.2040-1124.2012.00207.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Yoshida H, Tada H, Ito K, Kishimoto Y, Yanai H, Okamura T, Ikewaki K, Inagaki K, Shoji T, Bujo H, Miida T, Yoshida M, Kuzuya M and Yamashita S: Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals. J Atheroscler Thromb, 2020; 27: 409-417","DOI":"10.5551\/jat.50187"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H and Hishida A: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M, Ito S, Itoh H, Iwao H, Kai H, Kario K, Kashihara N, Kawano Y, Kim-Mitsuyama S, Kimura G, Kohara K, Komuro I, Kumagai H, Matsuura H, Miura K, Morishita R, Naruse M, Node K, Ohya Y, Rakugi H, Saito I, Saitoh S, Shimada K, Shimosawa T, Suzuki H, Tamura K, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Umemura S, Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res, 2014; 37: 253-390","DOI":"10.1038\/hr.2014.68"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Harada-Shiba M, Arai H, Ishigaki Y, Ishibashi S, Okamura T, Ogura M, Dobashi K, Nohara A, Bujo H, Miyauchi K, Yamashita S, Yokote K and Working Group by Japan Atherosclerosis Society for Making Guidance of Familial Hypercholesterolemia: Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017. J Atheroscler Thromb, 2018; 25: 751-770","DOI":"10.5551\/jat.CR003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Friedewald WT, Levy RI and Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Cederberg H, Gylling H, Miettinen TA, Paananen J, Vangipurapu J, Pihlajam\u00e4ki J, Kuulasmaa T, Stan\u010d\u00e1kov\u00e1 A, Smith U, Kuusisto J, Laakso M: Non-cholesterol sterol levels predict hyperglycemia and conversion to type 2 diabetes in Finnish men. PLoS One, 2013; 8(6): e67406","DOI":"10.1371\/journal.pone.0067406"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Gylling H, Laaksonen DE, Atalay M, Hallikainen M, Niskanen L, Miettinen TA: Markers of absorption and synthesis of cholesterol in men with type 1 diabetes. Diabetes Metab Res Rev, 2007; 23: 372-377","DOI":"10.1002\/dmrr.697"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Mashnafi S, Plat J, Mensink RP, Baumgartner S: Non-Cholesterol Sterol Concentrations as Biomarkers for Cholesterol Absorption and Synthesis in Different Metabolic Disorders: A Systematic Review. Nutrients, 2019; 11: 124","DOI":"10.3390\/nu11010124"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Lally S, Owens D, Tomkin GH: The different effect of pioglitazone as compared to insulin on expression of hepatic and intestinal genes regulating post-prandial lipoproteins in diabetes. Atherosclerosis, 2007; 193: 343-351","DOI":"10.1016\/j.atherosclerosis.2006.09.031"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Levy E, Lalonde G, Delvin E, Elchebly M, Pr\u00e9court LP, Seidah NG, Spahis S, Rabasa-Lhoret R, Ziv E: Intestinal and hepatic cholesterol carriers in diabetic Psammomys obesus. Endocrinology, 2010; 151: 958-970","DOI":"10.1210\/en.2009-0866"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Ravid Z, Bendayan M, Delvin E, Sane AT, Elchebly M, Lafond J, Lambert M, Mailhot G, Levy E: Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors. Am J Physiol Gastrointest Liver Physiol, 2008; 295: G873-885","DOI":"10.1152\/ajpgi.90376.2008"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Malhotra P, Boddy CS, Soni V, Saksena S, Dudeja PK, Gill RK, Alrefai WA: D-Glucose modulates intestinal Niemann-Pick C1-like 1 (NPC1L1) gene expression via transcriptional regulation. Am J Physiol Gastrointest Liver Physiol, 2013; 304: G203-G210","DOI":"10.1152\/ajpgi.00288.2012"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Miettinen TA, Gylling H: Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis, 2000; 153: 241-248","DOI":"10.1016\/S0021-9150(00)00404-4"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Simonen PP, Gylling H, Miettinen TA: The distribution of squalene and non-cholesterol sterols in type 2 diabetes. Atherosclerosis, 2007; 194: 222-229","DOI":"10.1016\/j.atherosclerosis.2006.07.030"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Simonen PP, Gylling H, Miettinen TA: The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes. Atherosclerosis, 2008; 197: 883-888","DOI":"10.1016\/j.atherosclerosis.2007.08.003"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Shimabukuro M, Higa M, Yamakawa K, Masuzaki H, Sata M: Miglitol, alpha-glycosidase inhibitor, reduces visceral fat accumulation and cardiovascular risk factors in subjects with the metabolic syndrome: a randomized comparable study. Int J Cardiol, 2013; 167: 2108-2113","DOI":"10.1016\/j.ijcard.2012.05.109"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Iijima T, Aoki K, Kondo Y, Terauchi Y: Comparison of lipid-lowering effects of anagliptin and miglitol in patients with type 2 diabetes: A randomized trial. J Clin Med Res, 2020; 12: 73-78","DOI":"10.14740\/jocmr4084"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Han T, Lv Y, Wang S, Hu T, Hong H, Fu Z: PPAR\u03b3 overexpression regulates cholesterol metabolism in human L02 hepatocytes. J Pharmacol Sci, 2019; 139: 240-248","DOI":"10.1016\/j.jphs.2018.09.013"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Chan DC, Watts GF, Barrett PH, O\u2019Neill FH, Redgrave TG, Thompson GR: Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome. Clin Sci(Lond), 2003; 104: 383-388","DOI":"10.1042\/cs1040383"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Ooi EM, Ng TW, Chan DC, Watts GF: Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes. Diabetes Res Clin Pract, 2009; 85: 310-316","DOI":"10.1016\/j.diabres.2009.06.003"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Cof\u00e1n M, Escurriol V, Garc\u00eda-Ot\u00edn AL, Moreno-Iribas C, Larra\u00f1aga N, S\u00e1nchez MJ, Tormo MJ, Redondo ML, Gonz\u00e1lez CA, Corella D, Pocov\u00ed M, Civeira F, Ros E: Association of plasma markers of cholesterol homeostasis with metabolic syndrome components. A cross-sectional study. Nutr Metab Cardiovasc Dis, 2011; 21: 651-657","DOI":"10.1016\/j.numecd.2010.01.005"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Matsuo M: ABC-binding cassette proteins involved in glucose and lipid homeostasis. Biosci Biotechnol Biochem, 2010; 74: 899-907","DOI":"10.1271\/bbb.90921"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Paramsothy P, Knopp RH, Kahn SE, Retzlaff BM, Fish B, Ma L, Ostlund RE Jr: Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity. Am J Clin Nutr, 2011; 94: 1182-1188","DOI":"10.3945\/ajcn.110.006668"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR: Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ, 2009; 338: b2393","DOI":"10.1136\/bmj.b2393"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Schroor MM, Sennels HP, Fahrenkrug J, J\u00f8rgensen HL, Plat J, Mensink RP: Diurnal variation of markers for cholesterol synthesis, cholesterol absorption, and bile acid synthesis: A systematic review and the bispebjerg study of diurnal variations. Nutrients, 2019; 11: 1439","DOI":"10.3390\/nu11071439"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/7\/30_63725\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:49:52Z","timestamp":1715316592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/7\/30_63725\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63725","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]},"article-number":"63725"}}